{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:33:20Z","timestamp":1790573600327,"version":"4.1.0"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T00:00:00Z","timestamp":1581379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2020.00076","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T04:39:20Z","timestamp":1581395960000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":96,"title":["RANKL\/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies"],"prefix":"10.3389","volume":"8","author":[{"given":"Xiaoqiu","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,11]]},"reference":[{"key":"B1","first-page":"604","article-title":"Technology evaluation: denosumab, Amgen.","volume":"7","author":"Abrahamsen","year":"2005","journal-title":"Curr. Opin. Mol. Ther."},{"key":"B2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/cbt.7.1.5163","article-title":"Biology of breast cancer bone metastasis.","volume":"7","author":"Akhtari","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"44347","DOI":"10.1074\/jbc.m202009200","article-title":"A RANK\/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function.","volume":"277","author":"Armstrong","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1586\/era.12.177","article-title":"Targeting RANKL in breast cancer: bone metastasis and beyond.","volume":"13","author":"Azim","year":"2013","journal-title":"Expert Rev. Anticancer Ther."},{"key":"B5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects.","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"B6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.4161\/cam.3.4.9211","article-title":"Site-specific metastasis formation: chemokines as regulators of tumor cell adhesion, motility and invasion.","volume":"3","author":"Ben-Baruch","year":"2009","journal-title":"Cell Adh. Migr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/ncponc0381","article-title":"Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis.","volume":"3","author":"Blair","year":"2006","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1902\/jop.2004.75.9.1247","article-title":"The role of parathyroid hormone\u2212related protein in the regulation of osteoclastogenesis by cementoblasts.","volume":"75","author":"Boabaid","year":"2004","journal-title":"J. Periodontol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/cncr.11138","article-title":"A phase I study of AMGN\u22120007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases.","volume":"97","author":"Body","year":"2003","journal-title":"Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10911-010-9174-0","article-title":"Epithelial-to-mesenchymal transitions and circulating tumor cells.","volume":"15","author":"Bonnomet","year":"2010","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"B11","article-title":"Medical physiology: a cellular and molecular approach.","author":"Boron","year":"2005"},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1186\/ar2165","article-title":"Biology of RANK, RANKL, and osteoprotegerin.","volume":"9","author":"Boyce","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"B13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","article-title":"Functions of RANKL\/RANK\/OPG in bone modeling and remodeling.","volume":"473","author":"Boyce","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"B14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation.","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s0065-3233(05)70009-7","article-title":"Molecular structure of the collagen triple helix.","volume":"70","author":"Brodsky","year":"2005","journal-title":"Adv. Protein Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s10585-007-9127-1","article-title":"Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis.","volume":"25","author":"Canon","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-007702","article-title":"Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval.","volume":"5","author":"Cetin","year":"2015","journal-title":"BMJ Open"},{"key":"B18","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/jcp.21430","article-title":"Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway.","volume":"216","author":"Chamoux","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.molmed.2014.06.001","article-title":"Osteoclasts: more than \u2018bone eaters\u2019.","volume":"20","author":"Charles","year":"2014","journal-title":"Trends Mol. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S1470-2045(13)70277-8","article-title":"Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.","volume":"14","author":"Chawla","year":"2013","journal-title":"Lancet Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/cncr.21978","article-title":"Expression of RANKL\/RANK\/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation.","volume":"107","author":"Chen","year":"2006","journal-title":"Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2781","article-title":"Breast cancer metastasis to the bone: mechanisms of bone loss.","volume":"12","author":"Chen","year":"2010","journal-title":"Breast Cancer Res."},{"key":"B23","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1615\/CritRevEukarGeneExpr.v10.i2.50","article-title":"Molecular mechanisms of tumor-bone interactions in osteolytic metastases.","volume":"10","author":"Chirgwin","year":"2000","journal-title":"Crit. Rev. Eukaryot. Gene Exp."},{"key":"B24","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.2215\/CJN.04151206","article-title":"Normal bone anatomy and physiology.","volume":"3","author":"Clarke","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1677\/erc.1.00543","article-title":"Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.","volume":"12","author":"Clines","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1053\/sonc.2002.37415","article-title":"Bisphosphonates for the prevention of bone metastases.","volume":"29","author":"Coleman","year":"2002","journal-title":"Sem. Oncol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.breast.2004.09.004","article-title":"The role of bisphosphonates in breast cancer.","volume":"13","author":"Coleman","year":"2004","journal-title":"Breast"},{"key":"B28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00109-013-1084-3","article-title":"Function of matrix IGF-1 in coupling bone resorption and formation.","volume":"92","author":"Crane","year":"2014","journal-title":"J. Mol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis.","volume":"361","author":"Cummings","year":"2009","journal-title":"N. Eng. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1093\/hmg\/11.18.2119","article-title":"A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype.","volume":"11","author":"Cundy","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1084\/jem.20190158","article-title":"Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis.","volume":"216","author":"Dai","year":"2019","journal-title":"J. Exp. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10555-006-9021-3","article-title":"The RANK\/RANKL\/OPG triad in cancer-induced bone diseases.","volume":"25","author":"Dougall","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"14363","DOI":"10.1074\/jbc.273.23.14363","article-title":"Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.","volume":"273","author":"Emery","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s0092-8674(00)00103-3","article-title":"The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development.","volume":"103","author":"Fata","year":"2000","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1073\/pnas.98.4.1853","article-title":"Integrin activation controls metastasis in human breast cancer.","volume":"98","author":"Felding-Habermann","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the\u2019seed and soil\u2019hypothesis revisited.","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"B37","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/421746","article-title":"Biology of bone tissue: structure, function, and factors that influence bone cells.","volume":"2015","author":"Florencio-Silva","year":"2015","journal-title":"BioMed Res. Int."},{"key":"B38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature09495","article-title":"RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis.","volume":"468","author":"Gonzalez-Suarez","year":"2010","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1101\/gad.1854909","article-title":"Breaking down bone: new insight into site-specific mechanisms of breast cancer osteolysis mediated by metalloproteinases.","volume":"23","author":"Guise","year":"2009","journal-title":"Genes Dev."},{"key":"B40","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.3816\/CBC.2005.s.004","article-title":"Molecular mechanisms of breast cancer metastases to bone.","volume":"5","author":"Guise","year":"2005","journal-title":"Clin. Breast Cancer"},{"key":"B41","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1016\/S0021-9258(18)67143-1","article-title":"Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose.","volume":"261","author":"Hauschka","year":"1986","journal-title":"J. Biol. Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"627.e5","DOI":"10.1016\/j.cmet.2018.12.021","article-title":"Autoregulation of osteocyte sema3a orchestrates estrogen action and counteracts bone aging.","volume":"29","author":"Hayashi","year":"2019","journal-title":"Cell Metab."},{"key":"B43","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.febslet.2012.02.037","article-title":"Regulation of EMT by TGF\u03b2 in cancer.","volume":"586","author":"Heldin","year":"2012","journal-title":"FEBS Lett."},{"key":"B44","doi-asserted-by":"publisher","first-page":"36846","DOI":"10.1074\/jbc.m606656200","article-title":"Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-\u03baB ligand.","volume":"281","author":"Hikita","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s001090100226","article-title":"Role of receptor activator of nuclear factor-\u03baB ligand and osteoprotegerin in bone cell biology.","volume":"79","author":"Hofbauer","year":"2001","journal-title":"J. Mol. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3892\/ol.2013.1372","article-title":"A new emergency in oncology: bone metastases in breast cancer patients.","volume":"6","author":"Ibrahim","year":"2013","journal-title":"Oncol. Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-018-0482-7","article-title":"Coupling of bone resorption and formation by RANKL reverse signalling.","volume":"561","author":"Ikebuchi","year":"2018","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1210\/endo.142.4.8070","article-title":"Determination of three isoforms of the receptor activator of nuclear factor-\u03baB ligand and their differential expression in bone and thymus.","volume":"142","author":"Ikeda","year":"2001","journal-title":"Endocrinology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"17.e6","DOI":"10.1016\/j.ccell.2018.12.002","article-title":"Gain fat-lose metastasis: converting invasive breast cancer cells into adipocytes inhibits cancer metastasis.","volume":"35","author":"Ishay-Ronen","year":"2019","journal-title":"Cancer Cell"},{"key":"B50","doi-asserted-by":"crossref","first-page":"P3-01-14","DOI":"10.1158\/0008-5472.SABCS11-P3-01-14","article-title":"P3-01-14: RANK and RANK Ligand (RANKL) expression in invasive breast carcinoma and human breast cancer cell lines AACR).","volume":"71","author":"Jacob","year":"2011","journal-title":"Cancer Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41586-019-1105-7","article-title":"Developmental origin, functional maintenance and genetic rescue of osteoclasts.","volume":"568","author":"Jacome-Galarza","year":"2019","journal-title":"Nature"},{"key":"B52","first-page":"23","article-title":"Targeting breast cancer metastasis.","volume":"9","author":"Jin","year":"2015","journal-title":"Breast Cancer"},{"key":"B53","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL.","volume":"440","author":"Jones","year":"2006","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","first-page":"24571","DOI":"10.1074\/jbc.m202561200","article-title":"Transforming growth factor-\u03b2 stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways.","volume":"277","author":"K\u00e4k\u00f6nen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17101674","article-title":"Cancer cell colonisation in the bone microenvironment.","volume":"17","author":"Kan","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/s1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone.","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer Cell"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1128\/mcb.26.3.1002-1013.2006","article-title":"Receptor activator of NF-\u03baB ligand regulates the proliferation of mammary epithelial cells via Id2.","volume":"26","author":"Kim","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-642-02400-9_2","article-title":"Physiology of bone formation, remodeling, and metabolism.","volume":"3","author":"Kini","year":"2012","journal-title":"Radionucl. Hybrid Bone Imaging"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/emboj\/20.6.1271","article-title":"Segregation of TRAF6\u2212mediated signaling pathways clarifies its role in osteoclastogenesis.","volume":"20","author":"Kobayashi","year":"2001","journal-title":"EMBO J."},{"key":"B60","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10911-005-5399-8","article-title":"Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy.","volume":"10","author":"Kozlow","year":"2005","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"B61","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis.","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1002\/ijc.26031","article-title":"The seed and soil hypothesis revisited\u2014The role of tumor\u2212stroma interactions in metastasis to different organs.","volume":"128","author":"Langley","year":"2011","journal-title":"Int. J. Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jbo.2016.02.008","article-title":"The role of osteoclasts in breast cancer bone metastasis.","volume":"5","author":"Le Pape","year":"2016","journal-title":"J. Bone Oncol."},{"key":"B64","first-page":"380","article-title":"Comparison of denosumab versus zoledronic acid (ZA) for treatment of bone metastases in advanced cancer patients: an integrated analysis of 3 pivotal trials.","volume":"21","author":"Lipton","year":"2010","journal-title":"Ann. Oncol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nm.4076","article-title":"LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption.","volume":"22","author":"Luo","year":"2016","journal-title":"Nat. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1200\/JCO.2009.27.5040","article-title":"Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer.","volume":"28","author":"Maki","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1152\/physrev.00024.2002","article-title":"Clinical, cellular, and molecular aspects of cancer invasion.","volume":"83","author":"Mareel","year":"2003","journal-title":"Physiol. Rev."},{"key":"B68","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1158\/1078-0432.ccr-11-3310","article-title":"Bone-related complications and quality of life in advanced breast cancer: results from a randomized phase III trial of denosumab versus zoledronic acid.","volume":"18","author":"Martin","year":"2012","journal-title":"Clin Cancer Res."},{"key":"B69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1022995403081","article-title":"The skeleton as a unique environment for breast cancer cells.","volume":"20","author":"Mastro","year":"2003","journal-title":"Clin. Exp. Metastasis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11914-009-0004-5","article-title":"Denosumab: anti-RANKL antibody.","volume":"7","author":"Miller","year":"2009","journal-title":"Curr. Osteoporos. Rep."},{"key":"B71","doi-asserted-by":"crossref","first-page":"39548","DOI":"10.1074\/jbc.M300539200","article-title":"Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kB (RANK) in endothelial cells: Concomitant increase of angiogenic responses to RANK ligand.","volume":"278","author":"Min","year":"2003","journal-title":"J. Biol. Chem."},{"key":"B72","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1210\/en.2004-1583","article-title":"The RANKL inhibitor osteoprotegerin (OPG) causes greater suppression of bone resorption and hypercalcemia compared to bisphosphonates in two models of humoral hypercalcemia of malignancy.","volume":"146","author":"Morony","year":"2005","journal-title":"Endocrinology"},{"key":"B73","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis.","volume":"410","author":"M\u00fcller","year":"2001","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities.","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"B75","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1159\/000371845","article-title":"The rankl-rank story.","volume":"61","author":"Nagy","year":"2015","journal-title":"Gerontology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1023\/b:brea.0000036900.48763.b3","article-title":"Osteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosis.","volume":"86","author":"Neville-Webbe","year":"2004","journal-title":"Breast Cancer Res. Treat."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1158\/0008-5472.CAN-12-0044","article-title":"RANK induces epithelial\u2013mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.","volume":"72","author":"Palafox","year":"2012","journal-title":"Cancer Res."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1096\/fj.01-0911fje","article-title":"Integrin \u03b1v\u03b23 expression confers on tumor cells a greater propensity to metastasize to bone.","volume":"16","author":"Pecheur","year":"2002","journal-title":"FASEB J."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/s0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future.","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"key":"B80","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrd3244","volume":"9","author":"Rizzoli","year":"2010","journal-title":"Denosumab. Nat. Rev. Drug Discov."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.","volume":"23","author":"Saad","year":"2011","journal-title":"Ann. Oncol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1210\/er.2006-0001","article-title":"The role of the IGF system in cancer growth and metastasis: overview and recent insights.","volume":"28","author":"Samani","year":"2007","journal-title":"Endocr. Rev."},{"key":"B83","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1210\/endo.141.12.7849","article-title":"Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines.","volume":"141","author":"Sanders","year":"2000","journal-title":"Endocrinology"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019234","article-title":"Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients.","volume":"6","author":"Santini","year":"2011","journal-title":"PLoS One"},{"key":"B85","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/01.atv.0000012303.37971.da","article-title":"RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function.","volume":"22","author":"Schoppet","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B86","first-page":"311","article-title":"Breast cancer metastasis.","volume":"9","author":"Scully","year":"2012","journal-title":"Cancer Genomics Proteomics"},{"key":"B87","first-page":"209","article-title":"Rank\/Rankl\/opg: literature review.","volume":"36","author":"Silva","year":"2011","journal-title":"Acta Reumatol. Port."},{"key":"B88","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.2147\/OTT.S135867","article-title":"The RANK\/RANKL\/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy.","volume":"10","author":"Sisay","year":"2017","journal-title":"Onco Targets Ther."},{"key":"B89","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2217\/fon.12.76","article-title":"The multifaceted actions of PTHrP in skeletal metastasis.","volume":"8","author":"Soki","year":"2012","journal-title":"Future Oncol."},{"key":"B90","article-title":"RANK-RANKL signaling inhibition delays early breast cancer bone metastasis formation. AACR)","author":"Sousa","year":"2018","journal-title":"Proceedings of the American Association for Cancer Research Annual Meeting."},{"key":"B91","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study.","volume":"28","author":"Stopeck","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10555-010-9256-x","article-title":"CXCL12\/CXCR4\/CXCR7 chemokine axis and cancer progression.","volume":"29","author":"Sun","year":"2010","journal-title":"Cancer Metastasis Rev."},{"key":"B93","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1359\/jbmr.041109","article-title":"Skeletal localization and neutralization of the SDF\u22121 (CXCL12)\/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.","volume":"20","author":"Sun","year":"2005","journal-title":"J. Bone Min. Res."},{"key":"B94","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1677\/ERC-09-0012","article-title":"Mechanisms of bone metastases of breast cancer.","volume":"16","author":"Suva","year":"2009","journal-title":"Endocr. Rrelat. Cancer"},{"key":"B95","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nrg1122","article-title":"Genetic regulation of osteoclast development and function.","volume":"4","author":"Teitelbaum","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"B96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012.","volume":"65","author":"Torre","year":"2015","journal-title":"Cancer J. Clin."},{"key":"B97","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/s8756-3282(99)00210-0","article-title":"Osteoblasts\/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor\/RANKL but not macrophage colony-stimulating factor.","volume":"25","author":"Udagawa","year":"1999","journal-title":"Bone"},{"key":"B98","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: molecular insights and evolving paradigms.","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"B99","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molmed.2005.11.007","article-title":"RANKL\u2013RANK signaling in osteoclastogenesis and bone disease.","volume":"12","author":"Wada","year":"2006","journal-title":"Trends Mol. Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/s0959-437x(01)00259-3","article-title":"TGF-\u03b2 signaling: positive and negative effects on tumorigenesis.","volume":"12","author":"Wakefield","year":"2002","journal-title":"Curr. Opin. Gnet. Dev."},{"key":"B101","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.0105-2896.2009.00857.x","article-title":"Bone remodeling in rheumatic disease: a question of balance.","volume":"233","author":"Walsh","year":"2010","journal-title":"Immunol. Rev."},{"key":"B102","doi-asserted-by":"publisher","first-page":"823.e7","DOI":"10.1016\/j.ccell.2018.10.002","article-title":"The Osteogenic niche is a calcium reservoir of bone micrometastases and confers unexpected therapeutic vulnerability.","volume":"34","author":"Wang","year":"2018","journal-title":"Cancer Cell"},{"key":"B103","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ccell.2014.11.017","article-title":"The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cells.","volume":"27","author":"Wang","year":"2015","journal-title":"Cancer Cell"},{"key":"B104","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cmet.2018.12.014","article-title":"A \u201cConnexin\u201d responsible for the fatal attraction of cancer to bone.","volume":"29","author":"Waning","year":"2019","journal-title":"Cell Metab."},{"key":"B105","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction.","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"B106","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJMoa013096","article-title":"Osteoprotegerin deficiency and juvenile Paget\u2019s disease.","volume":"347","author":"Whyte","year":"2002","journal-title":"N. Eng. J. Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"28355","DOI":"10.1074\/jbc.273.43.28355","article-title":"The TRAF family of signal transducers mediates NF-\u03baB activation by the TRANCE receptor.","volume":"273","author":"Wong","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/nm.2448","article-title":"Matrix-embedded cells control osteoclast formation.","volume":"17","author":"Xiong","year":"2011","journal-title":"Nat. Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1172\/jci3523","article-title":"TGF-\u03b2 signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development.","volume":"103","author":"Yin","year":"1999","journal-title":"J. Clin. Investigat."},{"key":"B110","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5312\/wjo.v4.i4.178","article-title":"Role of RANKL\/RANK in primary and secondary breast cancer.","volume":"4","author":"Yoneda","year":"2013","journal-title":"World J. Orthopedics"},{"key":"B111","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jbo.2012.11.002","article-title":"The role of the bone microenvironment in skeletal metastasis.","volume":"2","author":"Zheng","year":"2013","journal-title":"J. Bone Oncol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00076\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T06:21:07Z","timestamp":1665814867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00076\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,11]]},"references-count":111,"alternative-id":["10.3389\/fcell.2020.00076"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2020.00076","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,11]]},"article-number":"76"}}